Michael R. Jaff, DO

Susan M. Begelman, MD
Nuvelo, Inc., San Carlos, CA

Michael R. Jaff, DO
Harvard Medical School and Massachusetts General Hospital, Boston, MA

Correspondence: Susan M. Begelman, MD, FACC, Associate Director, Clinical Sciences/Cardiovascular, Nuvelo, Inc., 201 Industrial Road, Suite 310, San Carlos, CA 94070–6211; sbegelman@nuvelo.com

Dr. Begelman reported that she has no financial relationships that pose a potential conflict of interest with this article.

Dr. Jaff reported that he has received honoraria for teaching and speaking from the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.

At the time this article was written, Dr. Begelman was employed in the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH.

Susan M. Begelman, MD
Nuvelo, Inc., San Carlos, CA

Michael R. Jaff, DO
Harvard Medical School and Massachusetts General Hospital, Boston, MA

Correspondence: Susan M. Begelman, MD, FACC, Associate Director, Clinical Sciences/Cardiovascular, Nuvelo, Inc., 201 Industrial Road, Suite 310, San Carlos, CA 94070–6211; sbegelman@nuvelo.com

Dr. Begelman reported that she has no financial relationships that pose a potential conflict of interest with this article.

Dr. Jaff reported that he has received honoraria for teaching and speaking from the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.

At the time this article was written, Dr. Begelman was employed in the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH.

Susan M. Begelman, MD
Nuvelo, Inc., San Carlos, CA

Michael R. Jaff, DO
Harvard Medical School and Massachusetts General Hospital, Boston, MA

Correspondence: Susan M. Begelman, MD, FACC, Associate Director, Clinical Sciences/Cardiovascular, Nuvelo, Inc., 201 Industrial Road, Suite 310, San Carlos, CA 94070–6211; sbegelman@nuvelo.com

Dr. Begelman reported that she has no financial relationships that pose a potential conflict of interest with this article.

Dr. Jaff reported that he has received honoraria for teaching and speaking from the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.

At the time this article was written, Dr. Begelman was employed in the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH.